keyword
https://read.qxmd.com/read/38847783/the-impact-of-underreported-infections-on-vaccine-effectiveness-estimates-derived-from-retrospective-cohort-studies
#1
JOURNAL ARTICLE
Chiara Sacco, Mattia Manica, Valentina Marziano, Massimo Fabiani, Alberto Mateo-Urdiales, Giorgio Guzzetta, Stefano Merler, Patrizio Pezzotti
BACKGROUND: Surveillance data and vaccination registries are widely used to provide real-time vaccine effectiveness (VE) estimates, which can be biased due to underreported (i.e. under-ascertained and under-notified) infections. Here, we investigate how the magnitude and direction of this source of bias in retrospective cohort studies vary under different circumstances, including different levels of underreporting, heterogeneities in underreporting across vaccinated and unvaccinated, and different levels of pathogen circulation...
April 11, 2024: International Journal of Epidemiology
https://read.qxmd.com/read/38847118/pertussis-outbreak-in-neonates-and-young-infants-across-italy-january-to-may-2024-implications-for-vaccination-strategies
#2
JOURNAL ARTICLE
Marco Poeta, Cristina Moracas, Chiara Albano, Laura Petrarca, Marco Maglione, Luca Pierri, Maurizio Carta, Paolo Montaldo, Elisabetta Venturini, Maia De Luca, Danilo Buonsenso, Ilaria Brambilla, Vania Giacomet, Andrea Lo Vecchio, Eugenia Bruzzese, Fabio Midulla, Claudia Colomba, Alfredo Guarino
Since January 2024, Italy experiences a pertussis outbreak, primarily affecting neonates and unvaccinated infants at high risk of severe complications and mortality; 11 major paediatric centres noted 108 hospitalisations and three deaths by 10 May. The outbreak reflects increased circulation of Bordetella pertussis and non-adherence to immunisation recommendations during pregnancy. Public health interventions, including maternal immunisation, vaccination of infants as early as possible and post-exposure prophylaxis, are critical for reducing the burden of pertussis and preventing further mortality...
June 2024: Euro Surveillance
https://read.qxmd.com/read/38846899/epidemiology-of-measles-in-southern-iran-trends-challenges-and-vaccination-insights
#3
JOURNAL ARTICLE
Mehdi Hassani Azad, Laya Dehghani Sargazi, Mojtaba Salari, Samaneh Jahangiri, Seyyed Mohammad Hashemi, Seyedeh Sahar Asadi, Ghasem Ghaedi Hengami, Arezoo Ghazalgoo, Mohammad-Hossein Keivanlou, Ehsan Amini-Salehi, Seyed Hossein Asadi Yousefabad
BACKGROUND: Measles, a highly contagious and vaccine-preventable disease, continues to present global public health challenges. This retrospective study focused on measles outbreaks in Hormozgan province, southern Iran, spanning from 2014 to 2019. METHODS: Between 2014 and 2019, patients suspected of having measles, as reported by medical centers in Hormozgan, were subject to a comprehensive evaluation. The diagnosis of measles was conclusively established through the use of real-time polymerase chain reaction (RT-PCR) testing...
June 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38845303/comparable-antibody-levels-in-heterologous-and-homologous-mrna-covid-19-vaccination-with-superior-neutralizing-and-iga-antibody-responses-in-mrna-homologous-boosting
#4
JOURNAL ARTICLE
Salma Younes, Eleonora Nicolai, Nadin Younes, Massimo Pieri, Sergio Bernardini, Parveen B Nizamuddin, Duaa W Al-Sadeq, Hanin I Daas, Ahmed Ismail, Hadi M Yassine, Laith J Abu-Raddad, Gheyath K Nasrallah
BACKGROUND: Priming with two doses of AZD1222 (Oxford-AstraZeneca; ChAd) followed by a third mRNA vaccine boosting is considered in several countries, yet comparisons between heterologous and homologous booster efficacy remain unexplored. AIM: To evaluate and contrast the immunogenicity of homologous and heterologous boosting regimens. METHOD: The study examined antibody responses in 1113 subjects, comprising 895 vaccine-naïve individuals across different vaccination strategies (partial, primary series, heterologous booster, homologous booster) and 218 unvaccinated, naturally infected individuals...
June 5, 2024: Vaccine
https://read.qxmd.com/read/38844494/vaccination-with-mincle-agonist-um-1098-and-mycobacterial-antigens-induces-protective-th1-and-th17-responses
#5
JOURNAL ARTICLE
Viktoria Rungelrath, Mushtaq Ahmed, Linda Hicks, Shannon M Miller, Kendal T Ryter, Kyle Montgomery, George Ettenger, Alexander Riffey, Walid M Abdelwahab, Shabaana Abdul Khader, Jay T Evans
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is one of the top infectious killers in the world. The only licensed vaccine against TB, Bacille Calmette-Guérin (BCG), provides variable protection against pulmonary TB, especially in adults. Hence, novel TB vaccine approaches are urgently needed. Both Th1 and Th17 responses are necessary for protection against TB, yet effective adjuvants and vaccine delivery systems for inducing robust Th1 and Th17 immunity are lacking. Herein we describe a synthetic Mincle agonist, UM-1098, and a silica nanoparticle delivery system that drives Th1/Th17 responses to Mtb antigens...
June 6, 2024: NPJ Vaccines
https://read.qxmd.com/read/38840159/how-effective-is-the-bnt162b2-mrna-vaccine-against-sars-cov-2-transmission-and-infection-a-national-programme-analysis-in-monaco-july-2021-to-september-2022
#6
JOURNAL ARTICLE
Thomas Althaus, Christopher E Overton, Isabelle Devaux, Thomas House, Arnaud Lapouze, Alexa Troel, Bertrand Vanzo, Margaux Laroche, Alexandre Bordero, Pernille Jorgensen, Richard Pebody, Eric J Voiglio
BACKGROUND: We quantified SARS-CoV-2 dynamics in different community settings and the direct and indirect effect of the BNT162b2 mRNA vaccine in Monaco for different variants of concern (VOC). METHODS: Between July 2021 and September 2022, we prospectively investigated 20,443 contacts from 6320 index cases using data from the Monaco COVID-19 Public Health Programme. We calculated secondary attack rates (SARs) in households (n = 13,877), schools (n = 2508) and occupational (n = 6499) settings...
June 5, 2024: BMC Medicine
https://read.qxmd.com/read/38840046/high-sars-cov-2-infection-rate-in-children-unvaccinated-with-covid-19-vaccine-in-changzhou-china-shortly-after-lifting-zero-covid-19-policy-in-december-2022
#7
JOURNAL ARTICLE
Jie Tang, Yong Wang, Weiqin Lu, Zhihong Gao, Mingfeng Xu, Lin Wu, Jianhua Jin
BACKGROUND: China experienced an overwhelming COVID-19 pandemic from middle December 2022 to middle January 2023 after lifting the zero-COVID-19 policy on December 7, 2022. However, the infection rate was less studied. We aimed to investigate the SARS-CoV-2 infection rate in children shortly after discontinuation of the zero-COVID-19 policy. METHODS: From February 20 to April 10, 2023, we included 393 children aged 8 months to less than 3 years who did not receive COVID-19 vaccination and 114 children aged 3 to 6 years who received inactivated COVID-19 vaccines based on the convenience sampling in this cross-sectional study...
June 5, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38838218/the-kinetics-and-durability-of-antibody-and-t-cell-responses-to-sars-cov-2-in-children
#8
JOURNAL ARTICLE
Megan A Files, Lauren Gentles, Leanne Kehoe, Amanda Adler, Kirsten Lacombe, Jane A Dickerson, Alexander Greninger, Alpana Waghmare, Tarayn Fairlie, Kimberly Pringle, Claire M Midgley, Melissa Briggs Hagen, Janet A Englund, Chetan Seshadri
BACKGROUND: The kinetics and durability of T-cell responses to SARS-CoV-2 in children are not well-characterized. We studied a cohort of children aged 6 months to 20 years with COVID-19 in whom peripheral blood mononuclear cells (PBMC) and sera were archived at approximately 1, 6, and 12 months post-symptom onset. METHODS: We compared antibody (N = 85) and T-cell responses (N = 26) to nucleocapsid (N) and spike (S) glycoprotein over time across four age strata: 6 months to 5 years, 5-9, 10-14, and 15-20 years...
June 5, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38837354/immune-responses-and-reinfection-of-sars-cov-2-omicron-variant-in-patients-with-lung-cancer
#9
JOURNAL ARTICLE
Chen Chen, Xiaoyun Zhou, Xiaoxing Gao, Ruili Pan, Qi He, Xiaobei Guo, Siyuan Yu, Na Wang, Qian Zhao, Mengzhao Wang, Yan Xu, Xiaohong Han
A significant Omicron wave emerged in China in December 2022. To explore the duration of humoral and cellular response postinfection and the efficacy of hybrid immunity in preventing Omicron reinfection in patients with lung cancer, a total of 447 patients were included in the longitudinal study after the Omicron wave from March 2023 to August 2023. Humoral responses were measured at pre-Omicron wave, 3 months and 7 months postinfection. The detected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific antibodies including total antibodies, anti-receptor binding domain (RBD) specific IgG, and neutralizing antibodies against SARS-CoV-2 wild type (WT) and BA...
June 5, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38836447/spray-vaccination-with-a-newcastle-disease-virus-ndv-vectored-infectious-laryngotracheitis-ilt-vaccine-protects-commercial-chickens-from-ilt-in-the-presence-of-maternally-derived-antibodies
#10
JOURNAL ARTICLE
Zhe Zeng, Zichen Wang, Xin Wang, Lun Yao, Yu Shang, Helong Feng, Hongcai Wang, Huabin Shao, Qingping Luo, Guoyuan Wen
<b/>Infectious laryngotracheitis (ILT) poses a significant threat to the poultry industry, and vaccines play an important role in protection. However, due to the increasing scale of poultry production, there is an urgent need to develop vaccines that are suitable for convenient immunization methods such as spraying. Previous studies have shown that Newcastle disease virus (NDV)-ILT vaccines administered via intranasal and intraocular routes to commercial chickens carrying maternally derived antibodies (MDAs) are still protective against ILT...
June 5, 2024: Avian Pathology: Journal of the W.V.P.A
https://read.qxmd.com/read/38836382/patients-with-advanced-cancer-were-treated-with-immune-checkpoint-inhibitors-and-injected-with-covid-19-vaccine-to-improve-their-prognosis-without-increasing-pancreatic-related-adverse-events
#11
JOURNAL ARTICLE
Min Li, Lingling Liao, Wei Huang, Hui Feng, Wanqing Wang, Nana Huang, Zhiyan Zhao, Yu Shi, Jinglu Ye, Kangsheng Gu
To investigate immune checkpoint inhibitors (ICIs) induced pancreatic injury (ICIPI), the prognostic effect of COVID-19 vaccine on cancer patients, and whether COVID-19 vaccine increases the incidence of ICIPI. We conducted a retrospective study of 256 stage IV cancer patients treated with ICIs at The First Affiliated Hospital of Anhui Medical University from January 2020 to November 2022. Data collected included pancreatic enzyme levels, treatment outcomes, and vaccination status. Statistical significance was determined using the χ2 test and Kaplan-Meier method ( p  < ...
December 31, 2024: Human Vaccines & Immunotherapeutics
https://read.qxmd.com/read/38835792/clinical-characteristics-and-risk-factors-in-patients-with-sars-cov-2-omicron-variant-infection-complicated-with-cardiovascular-diseases
#12
JOURNAL ARTICLE
Xiao-Hua Yu, Yu-Wei Liao, Ling Rong, Bi-Gui Chen, Run-Jun Li, Guang-Kuan Zeng, Li-Li Liu, Yan-Bin Cao, Jian-Lian Liang, Bai-Ru Lai, Yan-Qing Zeng, Yu-Chan Huang, Li-Ye Yang
OBJECTIVE: To investigate the clinical characteristics and risk factors of patients with SARS-CoV-2 Omicron variant infection complicated with cardiovascular diseases. METHODS: A retrospective analysis of general clinical data was conducted on patients with SARS-CoV-2 omicron infection complicated with hypertension, coronary heart disease, and heart failure admitted to one hospital in Guangdong Province from December 1, 2022, to February 28, 2023. Clinical symptoms, laboratory tests, imaging examinations, treatment, and clinical outcomes were collected...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38834971/covid-19-and-long-term-impact-on-symptoms-and-health-related-quality-of-life-in-costa-rica-the-respira-cohort-study
#13
JOURNAL ARTICLE
Cristina Barboza-Solis, Romain Fantin, Allan Hildesheim, Ruth Pfeiffer, Carolina Porras, Julia Butt, Tim Waterboer, Henriette Raventós, Arturo Abdelnour, Amada Aparicio, Viviana Loria, D Rebecca Prevots, Mitchell H Gail, Rolando Herrero
BACKGROUND: Evidence continues to accumulate regarding the potential long-term health consequences of COVID-19 in the population. To distinguish between COVID-19-related symptoms and health limitations from those caused by other conditions, it is essential to compare cases with community controls using prospective data ensuring case-control status. The RESPIRA study addresses this need by investigating the lasting impact of COVID-19 on Health-related Quality of Life (HRQoL) and symptomatology in a population-based cohort in Costa Rica, thereby providing a robust framework for controlling HRQoL and symptoms...
June 4, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38834857/herpes-zoster-ophthalmicus-presentation-complications-treatment-and-prevention
#14
REVIEW
John Litt, Anthony L Cunningham, Francisco Arnalich-Montiel, Raunak Parikh
Herpes zoster (HZ) is caused by reactivation of latent infection of varicella zoster virus (VZV) in sensory (cranial, dorsal root) ganglia. Major risk factors for HZ are increasing age and immunosuppression. HZ ophthalmicus (HZO) is a subset of HZ with involvement of the ophthalmic division of the fifth cranial trigeminal nerve. Approximately 4-20% of patients with HZ develop HZO. Approximately 50% of patients with HZO develop ocular disease, among whom up to 25% develop chronic or recurrent disease. Common manifestations of ocular disease include conjunctivitis, keratitis, and uveitis, whereas optic neuropathy and retinitis are uncommon...
June 4, 2024: Infectious Diseases and Therapy
https://read.qxmd.com/read/38833299/covid-19-vaccine-effectiveness-and-digital-pandemic-surveillance-in-germany-ecov-study-web-application-based-prospective-observational-cohort-study
#15
JOURNAL ARTICLE
Anna-Lena Lang, Nils Hohmuth, Vukašin Višković, Stefan Konigorski, Stefan Scholz, Felix Balzer, Cornelius Remschmidt, Rasmus Leistner
BACKGROUND: The COVID-19 pandemic posed significant challenges to global health systems. Efficient public health responses required a rapid and secure collection of health data to improve the understanding of SARS-CoV-2 and examine the vaccine effectiveness (VE) and drug safety of the novel COVID-19 vaccines. OBJECTIVE: This study (COVID-19 study on vaccinated and unvaccinated subjects over 16 years; eCOV study) aims to (1) evaluate the real-world effectiveness of COVID-19 vaccines through a digital participatory surveillance tool and (2) assess the potential of self-reported data for monitoring key parameters of the COVID-19 pandemic in Germany...
June 4, 2024: Journal of Medical Internet Research
https://read.qxmd.com/read/38833210/mrna-vaccines-protect-from-the-lung-microvasculature-injury-and-the-capillary-blood-volume-loss-occurring-in-sars-cov-2-paucisymptomatic-infections
#16
JOURNAL ARTICLE
Roberto W Dal Negro, Paola Turco, Massimiliano Povero
INTRODUCTION: The reduction of lung capillary blood volume (Vc) had been identified as the microvascular injury mostly underlying the respiratory Long-COVID syndrome following post-COVID-19 pneumonia. The same kind of injury have been recently also found in several individuals after milder paucisymptomatic SARS-CoV-2 infections. Though current guidelines strongly recommend vac-cination, studies aimed to investigate the in vivo protection of anti-SARS-CoV-2 vaccines on lung microvascular targets still are missing to our best knowledge...
June 3, 2024: Multidisciplinary Respiratory Medicine
https://read.qxmd.com/read/38832478/vaccine-effectiveness-against-severe-acute-respiratory-syndrome-coronavirus-2-reinfection-by-type-and-frequency-of-vaccine-a-community-based-case-control-study
#17
JOURNAL ARTICLE
Hyerin Gim, Haesook Seo, Byung Chul Chun
BACKGROUND: Although guidelines recommend vaccination for individuals who have recovered from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to prevent reinfection, comprehensive evaluation studies are limited. We aimed to evaluate vaccine effectiveness against SARS-CoV-2 reinfection according to the primary vaccination status, booster vaccination status, and vaccination methods used. METHODS: This population-based case-control study enrolled all SARS-CoV-2-infected patients in Seoul between January 2020 and February 2022...
June 3, 2024: Journal of Korean Medical Science
https://read.qxmd.com/read/38832342/the-association-of-covid-19-vaccination-and-menstrual-health-a-period-tracking-app-based-cohort-study
#18
JOURNAL ARTICLE
Malini Ramaiyer, Malak El Sabeh, Jiafeng Zhu, Amanda Shea, Dorry Segev, Gayane Yenokyan, Mostafa A Borahay
BACKGROUND: In initial COVID-19 clinical trials, menstrual health was not formally monitored, yet anecdotal reports of menstruation changes surfaced on social media. This study aims to assess the association between COVID-19 vaccines and menstruation using Clue, a period-tracking application. STUDY DESIGN: A survey assessing demographics, menstrual health, stress levels, and COVID-19 vaccination was sent to Clue users between 12/7/2021 and 2/9/2022. Inclusion criteria were (1) 18 years or older (2) currently menstruating (3) not pregnant or breastfeeding since 1/2020...
August 2024: Vaccine: X
https://read.qxmd.com/read/38830902/titers-of-igg-and-iga-against-sars-cov-2-proteins-and-their-association-with-symptoms-in-mild-covid-19-infection
#19
JOURNAL ARTICLE
Andrés G Abril, Jose Alejandre, Anais Mariscal, Leticia Alserawan, Nuria Rabella, Eva Roman, Joaquin Lopez-Contreras, Ferran Navarro, Elena Serrano, Josep M Nomdedeu, Silvia Vidal
Humoral immunity in COVID-19 includes antibodies (Abs) targeting spike (S) and nucleocapsid (N) SARS-CoV-2 proteins. Antibody levels are known to correlate with disease severity, but titers are poorly reported in mild or asymptomatic cases. Here, we analyzed the titers of IgA and IgG against SARS-CoV-2 proteins in samples from 200 unvaccinated Hospital Workers (HWs) with mild COVID-19 at two time points after infection. We analyzed the relationship between Ab titers and patient characteristics, clinical features, and evolution over time...
June 3, 2024: Scientific Reports
https://read.qxmd.com/read/38830899/long-term-trial-of-protection-provided-by-adenovirus-vectored-vaccine-expressing-the-pprv-h-protein
#20
JOURNAL ARTICLE
Karin E Darpel, Amanda Corla, Anna Stedman, Fiona Bellamy, John Flannery, Paulina Rajko-Nenow, Claire Powers, Steve Wilson, Bryan Charleston, Michael D Baron, Carrie Batten
A recombinant, replication-defective, adenovirus-vectored vaccine expressing the H surface glycoprotein of peste des petits ruminants virus (PPRV) has previously been shown to protect goats from challenge with wild-type PPRV at up to 4 months post vaccination. Here, we present the results of a longer-term trial of the protection provided by such a vaccine, challenging animals at 6, 9, 12 and 15 months post vaccination. Vaccinated animals developed high levels of anti-PPRV H protein antibodies, which were virus-neutralising, and the level of these antibodies was maintained for the duration of the trial...
June 3, 2024: NPJ Vaccines
keyword
keyword
61965
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.